Jupiter Research Capital (Asia) Ltd’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135K Buy
+31,320
New +$132K 0.01% 639
2026
Q2
– Sell
-124,228
Closed -$559K – 988
2026
Q1
$559K Buy
+124,228
New +$647K 0.06% 362

Other funds holding MYGN

Jupiter Research Capital (Asia) Ltd's MYGN Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in Myriad Genetics (MYGN) in Q3 2026: 31,320 shares worth $135K. The stake represents 0.01% of the portfolio and ranks #639 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in MYGN as recently as Q1 2026.

Jupiter Research Capital (Asia) Ltd first reported a position in MYGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $559K in Q1 2026. 170 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 31,320 shares of Myriad Genetics worth $135K as of Q3 2026.
  • Myriad Genetics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • Myriad Genetics made up 0.01% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #639 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Myriad Genetics in Q1 2026 and has held it in 2 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Myriad Genetics position peaked at $559K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.